01 / ATLAS
What it is
NAD+ is nicotinamide adenine dinucleotide, a coenzyme involved in metabolic reactions. It is not a peptide; it is included because it frequently appears in the same discussions about metabolism. [1]
02 / ATLAS
How it works
NAD+ participates in electron transfer and cellular processes that consume this coenzyme. Its biological role does not demonstrate that an infusion provides an additional clinical benefit. [1]
03 / ATLAS
What research shows
A pilot study tracked changes in NAD+ and its metabolites in blood and urine. It did not demonstrate rejuvenation, treatment of fatigue or lifespan extension. [1]
04 / ATLAS
Study data
Grant et al., 2019: 11 men, including 8 in the NAD+ group and 3 controls; short-term measurements after infusion. The small sample and metabolic focus limit therapeutic conclusions. [1]
05 / ATLAS
Safety and observed adverse reactions
No adverse events were observed in the small group during follow-up. This does not establish long-term safety or safety in other populations and products. [1]
06 / ATLAS
Research status
Early clinical data on intravenous administration. Studies of precursors such as NR or NMN should not automatically be attributed to directly administered NAD+.
07 / REFERENCES
Studies and sources
- Grant et al. · NAD+ metabolism following infusion (2019) ↗Original research · pilot study